A Multi-centre, Open Label, Observational, Non-interventional Study to Evaluate the Safety and Effectiveness of Victoza (R) in Subjects With Type 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 14 Feb 2018
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 09 Sep 2016 Status changed from active, no longer recruiting to completed.
- 23 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 Jul 2011 New trial record